SCHEMBL1968894

SCHEMBL1968894

Nc1ccc(Oc2ccc3c(-c4ccccc4C(=O)O)c4ccc(=O)cc-4oc3c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 4/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
ABCB1 P08183 1/20 0.51
MEN1 O00255 2/20 0.50
POLB P06746 2/20 0.50
KMT2A Q03164 2/20 0.50
ALPL P05186 1/20 0.50
ALPI P09923 1/20 0.50
ALPG P10696 1/20 0.50
ATM Q13315 2/20 0.49
CFTR P13569 1/20 0.49
PAX8 Q06710 1/20 0.49
GOPC Q9HD26 1/20 0.49
PLEC Q15149 1/20 0.47
CA9 Q16790 8/20 0.47
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA12 O43570 4/20 0.47
FTO Q9C0B1 2/20 0.44
DNASE1L3 Q13609 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1971500 0.91 USP2 (0.63) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL3430200 0.88 USP2 (0.74) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL10205417 0.85 USP2 (0.58) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL18179747 0.85 USP2 (0.54) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL18932154 0.84 USP2 (0.56) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL15298865 0.83 USP2 (0.56) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL10268461 0.83 USP2 (0.55) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL31621793 0.83 USP2 (0.55) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL14527749 0.83 USP2 (0.55) USP2L3MBTL1ABCB1MEN1POLB
SCHEMBL12437910 0.83 USP2 (0.55) USP2L3MBTL1ABCB1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091673-A1 DISSOCIABLE NANOPARTICLES WITH INTER ALIA TRANSITION-METAL COMPLEX CATALYSTS OXFORD FINANCE LLC 2019-03-28 US claimed
EP-3172569-A1 ASSAY METHODS INVOLVING DISSOCIABLE NANOPARTICLES Selux Diagnostics Inc. (US) 2017-05-31 EP claimed
WO-2017015145-A2 DISSOCIABLE TRANSITION-METAL NANOPARTICLES SeLux Diagnostics, Inc. (US) 2017-01-26 WO claimed
WO-2016015027-A1 ASSAY METHODS INVOLVING DISSOCIABLE NANOPARTICLES SeLux Diagnostics, Inc. (US) 2016-01-28 WO claimed
US-20060211122-A1 Reagents for the measurement of peroxynitrites SEKISUI MEDICAL CO., LTD. (JP) 2006-09-21 US claimed
EP-1553409-A1 REAGENTS FOR THE MEASUREMENT OF PEROXYNITRITES DAIICHI PURE CHEMICALS CO., LTD. (JP) 2005-07-13 EP claimed
US-20260108485-A1 COMPOSITIONS AND METHODS FOR ACUTELY RAISING NITIC OXIDE LEVELS NATURE'S SUNSHINE PRODUCTS, INC. (US) 2026-04-23 US disclosed
EP-4051097-B1 AUTOMATED AND PRECISE DEVICE FOR DENTAL PLAQUE DETECTION, MONITORING AND REMOVAL UNIV PENNSYLVANIA (US) 2026-03-25 EP disclosed
CN-119619091-A Method and kit for detecting activity of intracellular myeloperoxidase by using flow cytometry 山东大学 2025-03-14 CN disclosed
WO-2024031149-A1 METHODS FOR THE DETECTION OF MYELOPEROXIDASE THE UNIVERSITY OF SYDNEY (AU) 2024-02-15 WO disclosed
EP-3436012-B1 MODIFIED WOUND DRESSINGS CONVATEC TECHNOLOGIES INC (US) 2023-09-20 EP disclosed
US-20230277712-A1 DEVICE TO GENERATE REACTIVE OXYGEN SPECIES (ROS) AND METHOD THEREOF GEORGE MASON UNIVERSITY 2023-09-07 US disclosed
US-20220346924-A1 AUTOMATED AND PRECISE DEVICE FOR DENTAL PLAQUE DETECTION, MONITORING AND REMOVAL THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-11-03 US disclosed
EP-1774276-A2 METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES Perkinelmer Las, Inc. (US) 2007-04-18 EP disclosed
US-20060211122-A1 Reagents for the measurement of peroxynitrites SEKISUI MEDICAL CO., LTD. (JP) 2006-09-21 US disclosed
US-20060211122-A1 Reagents for the measurement of peroxynitrites SEKISUI MEDICAL CO., LTD. (JP) 2006-09-21 US disclosed
WO-2006014424-A2 METHODS AND COMPOSITIONS FOR DETECTING AND ISOLATING PHOSPHORYLATED MOLECULES USING HYDRATED METAL OXIDES PERKINELMER LAS, INC. (US) 2006-02-09 WO disclosed
EP-1553409-A1 REAGENTS FOR THE MEASUREMENT OF PEROXYNITRITES DAIICHI PURE CHEMICALS CO., LTD. (JP) 2005-07-13 EP disclosed
EP-1553409-A1 REAGENTS FOR THE MEASUREMENT OF PEROXYNITRITES DAIICHI PURE CHEMICALS CO., LTD. (JP) 2005-07-13 EP disclosed
WO-2004040296-A1 REAGENTS FOR THE MEASUREMENT OF PEROXYNITRITES DAIICHI PURE CHEMICALS CO., LTD. (JP) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108485-A1 COMPOSITIONS AND METHODS FOR ACUTELY RAISING NITIC OXIDE LEVELS MPO, ARG2, NOS1 USP2 3765/4885L3MBTL1 2375/4885ABCB1 1644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.